Market Place
Sourcing Support
Pharmexcil announces strategic pharma cooperation between India and Taiwan
03 Jun 2024 //
PHARMABIZ
US FDA withdraws approval for Covis Pharma`s preterm birth prevention drug
07 Apr 2023 //
REUTERS
Controversial drug for preterm birth to be withdrawn, maker says
09 Mar 2023 //
BIOPHARMADIVE
Covis granted FDA hearing over premature-birth med Makena
21 Aug 2021 //
FIERCEPHARMA
FDA, unmoved by new meta-analysis, still recommends Makena withdrawal
30 Mar 2021 //
RAPS
AMAG Pharmaceuticals Requests Hearing to Maintain Makena®
14 Oct 2020 //
GLOBENEWSWIRE
FDA seeks withdrawal of Makena, generics from market
06 Oct 2020 //
RAPS
FDA Proposes Withdrawing Makena`s Approval
05 Oct 2020 //
MEDSCAPE
FDA seeks withdrawal of Makena, generics from market
05 Oct 2020 //
RAPS
Covis Group to acquire AMAG Pharmaceuticals in $647m deal
05 Oct 2020 //
PHARMAFILE
Covis Group to acquire AMAG Pharmaceuticals in $647m deal
05 Oct 2020 //
PHARMAFILE
Makena Withdrawal? A Look at the Timeline and Other Accelerated Approvals
01 Nov 2019 //
RAPS
FDA panel backs withdrawal of Amag drug to prevent preterm birth
31 Oct 2019 //
BIOPHARMADIVE
AMAG Pharmaceuticals Stock Trading Halted Today
29 Oct 2019 //
BIOSPACE
Amag Pharma shares halted pending outcome of Ad Com meeting
29 Oct 2019 //
SEEKINGALPHA
FDA review of troubled drug could hobble AMAG in proxy fight
27 Sep 2019 //
FIERCE PHARMA
Embattled AMAG braces for October FDA Makena adcom, but it need not worry
24 Sep 2019 //
ENDPTS
Aspen`s Generic Hydroxyprogesterone Caproate Receives Approval In US
14 Aug 2019 //
FDA
AM Regent`s Generic Hydroxyprogesterone Caproate Receives Approval in US
14 Aug 2019 //
FDA
Enforcement Report - Week of July 17, 2019
17 Jul 2019 //
FDA
Eugia Pharma Generic Hydroxyprogesterone Caproate Receives Approval in US
13 May 2019 //
FDA
Eugia Pharma`s Generic Hydroxyprogesterone Caproate Receives Approval in US
19 Apr 2019 //
FDA
Enforcement Report - Week of April 17, 2019
17 Apr 2019 //
FDA
Sun Pharms Generic Hydroxyprogesterone Caproate Receives Approval in US
11 Apr 2019 //
FDA
USPTO Grants Priority Motion To Lipocine And Enters Judgment Against Clarus
14 Jan 2019 //
PR NEWSWIRE
Enforcement Report - Week of January 9, 2019
09 Jan 2019 //
FDA
Inventive Infusion Solutions Receives FDA Form 483
27 Sep 2018 //
FDA
Luitpold Pharms Generic Hydroxyprogesterone Caproate Receives Approval In US
26 Jun 2018 //
FDA
FDA-approved preterm birth drug has no benefit & may cause harm, study suggests
15 Mar 2017 //
PHARMAFILE
US FDA approves AMAG Pharma`s single-dose Makena to reduce risk of preterm birth
24 Feb 2016 //
PHARMABIZ
Why "Price Gouging" May Come to an End
24 Nov 2015 //
BIOSPACE
FDA again rejects single-dose use of AMAG`s Makena
19 Nov 2015 //
REUTERS
McGuff Announces FDA Approval for Hydroxyprogesterone Caproate Injection
05 Oct 2015 //
PR NEWS WIRE
FDA Seeks More Info Before Approving AMAG Pharmaceuticals, Single-Dose Vial of Makena
28 May 2015 //
BIOSPACE
